Tumor necrosis factor alpha (TNFa) is a potent inhibitor of neurogenesis in vitro but here we show that TNFa signaling has both positive and negative effects on neurogenesis in vivo and is required to moderate the negative impact of cranial irradiation on hippocampal neurogenesis. In vitro, basal levels of TNFa signaling through TNFR2 are required for normal neural progenitor cell proliferation while basal signaling through TNFR1 impairs neural progenitor proliferation. TNFR1 also mediates further reductions in proliferation and elevated cell death following exposure to recombinant TNFa. In vivo, TNFR1
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animals have elevated baseline neurogenesis in the hippocampus, whereas absence of TNFR2 decreases baseline neurogenesis. TNFa is also implicated in defects in neurogenesis that follow radiation injury but we find that loss of TNFR1 has no protective effects on neurogenesis and loss of TNFa or TNFR2 worsened the effects of radiation injury on neurogenesis. We conclude that the immunomodulatory signaling of TNFa mediated by TNFR2 is more significant to radiation injury outcome than the proinflammatory signaling mediated through TNFR1. Ó 2013 Elsevier Inc. All rights reserved.
Introduction
Neuroinflammation is a common feature in many neurological diseases/disorders, such as Parkinson's disease, Alzheimer's disease, and stroke, etc. (Chen and Palmer, 2008; Liebigt et al., 2012; Liu and Hong, 2003; Nelson et al., 2002) . Previous studies have shown that microglia activation, a secondary consequence of neurological disease or injury, is detrimental to adult neurogenesis in the dentate gyrus (DG). Treatment with non-steroidal anti-inflammatory drugs can attenuate the effects on neurogenesis (Ekdahl et al., 2003; Monje et al., 2002 Monje et al., , 2003 ; however, the detrimental cytokine(s) produced by microglia and the molecular mechanisms underlying such effects are not completely known.
TNFa is a pleiotropic cytokine that is implicated in many immunological diseases/disorders but the precise influence of TNFa in adult neurogenesis remains controversial. Our earlier studies suggested that TNFa is a contributing factor in the inflammatory inhibition of neurogenesis (Monje et al., 2003) and Iosif et al. have shown that TNFR1-mediated signaling suppresses the proliferation of adult neural stem/progenitor cells (NSCs) within the DG (Iosif et al., 2006) . Keohane et al. (2010) report that TNFa treatment decreases neurogenesis in cultured NSCs but has no effect on proliferation (Keohane et al., 2010) . In contrast, Widera et al. (2006) show that TNFa treatment promotes NSC proliferation but has no effect on differentiation in culture (Widera et al., 2006) . These contrasting results suggest that the effect of TNFa signaling may be cell type-selective and/or context specific.
In the current study, we examined the effect of individual cytokines produced by activated microglia and found that exogenously applied recombinant TNFa exerts a conserved inhibitory effect on neuron production in mouse, primate and human NSC cultures but we also found that loss of TNFa or TNFR2 in vivo exacerbates the negative impact of radiation-induced inflammation on hippocampal neurogenesis while loss of TNFR1 has no significant influence on outcome. This implies that the most influential role for TNFa in chronically impaired neurogenesis that follows irradiation injury is a protective immunomodulatory effect mediated through TNFR2.
Materials and methods

Animals
C57BL/6J (wild-type, stock number 000664), C57BL/6-Tnfrsf1a , stock number 005540) -all on C57BL/6 background, were purchased from the Jackson laboratory (Bar Harbor, Maine). The mice were purchased as homozygous and the genotypes confirmed by PCR (data not shown). All animal protocols used in the present study have been reviewed and approved
